104 related articles for article (PubMed ID: 62114)
1. Active specific immunotherapy for ovarian cancer.
Hudson CN; McHardy JE; Curling OM; English PE; Levin L; Poulton TA; Crowther M; Leighton M
Lancet; 1976 Oct; 2(7991):877-9. PubMed ID: 62114
[TBL] [Abstract][Full Text] [Related]
2. Active specific immunotherapy in ovarian cancer.
Crowther ME; Levin L; Poulton TA; Saffrey MJ; Curling OM; Hudson CN
Recent Results Cancer Res; 1978; 68():166-73. PubMed ID: 752855
[No Abstract] [Full Text] [Related]
3. Bacillus Calmette-Guérin immunotherapy in ovarian cancer.
Pattillo RA; Komaki R; Reynolds M; Robles J
J Reprod Med; 1988 Jan; 33(1):41-5. PubMed ID: 3351805
[TBL] [Abstract][Full Text] [Related]
4. [Prolonged survival in adults with acute myeloid leukemia treated with BCG immunotherapy].
Vu Van H; Guyotat D; Fière D; Adeleine P; Gentilhomme O; Treille D; Imbert C; Coiffier B; Bryon PA; Viala JJ
Nouv Presse Med; 1982 Dec; 11(49):3637-9. PubMed ID: 6962421
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for acute myelogenous leukemia.
Powles RL; Lister TA; Crowther D; McElwain T; Alexander P; Fairley GH
Bibl Haematol; 1975; (40):737-49. PubMed ID: 1057948
[TBL] [Abstract][Full Text] [Related]
6. [Attempt at immunotherapy using BCG vaccine in acute leukemia].
Kardaszewicz E
Acta Haematol Pol; 1972; 3(3):251-6. PubMed ID: 4649308
[No Abstract] [Full Text] [Related]
7. [Non-lymphoblastic acute leukaemia: maintenance therapy by trial of a combination of chemo- and immunotherapy (author's transl)].
Sébahoun G; Gastaut JA; Imbert-Xeridat C; Favre R; Carcassonne Y
Nouv Presse Med; 1979 Feb; 8(9):663-5. PubMed ID: 377219
[TBL] [Abstract][Full Text] [Related]
8. Chemo immunotherapy of advanced breast cancer with BCG.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Buzdar A; Burgess MA; Richman SP; Tashima CK; Schwarz M; Hersh EM
Recent Results Cancer Res; 1977; (62):143-50. PubMed ID: 601328
[No Abstract] [Full Text] [Related]
9. BCG therapy in acute non lymphoid leukaemias.
Vuvan H; Fiere D; Doillon M; Martin C; Coiffier B; Felman P; Bryon PA; Favre-Gilly J; Revol L
Scand J Haematol; 1978 Jul; 21(1):40-6. PubMed ID: 358371
[TBL] [Abstract][Full Text] [Related]
10. Late intensification therapy for acute leukemia in remission. Chemotherapy and immunotherapy.
Bodey GP; Freireich EJ; Gehan E; McCredie KB; Rodriguez V; Gutterman J; Burgess MA
JAMA; 1976 Mar; 235(10):1021-5. PubMed ID: 946184
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of radiotherapy for state I ovarian carcinoma].
Sheng X; Sun J; Zhou C
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):314-6. PubMed ID: 9387332
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with chemotherapy in the maintenance of remission in acute myeloblastic leukaemia.
Whiteside MG; Cauchi MV; Paton CM
Med J Aust; 1976 Jul; 2(1):10-3. PubMed ID: 1068338
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory breast cancer treated with surgery, chemotherapy and allogeneic tumor cell/BCG immunotherapy.
Wiseman C; Jessup JM; Smith TL; Hersh E; Bowen J; Blumenshein G
Cancer; 1982 Mar; 49(6):1266-71. PubMed ID: 6800632
[TBL] [Abstract][Full Text] [Related]
14. Maximal cytoreduction, chemotherapy and contact nonspecific immunotherapy for stage III carcinoma of the ovary.
Papaioannou AN; Polychronis AB; Avgoustis AH; Coca HI; Trichopoulos DB
Surg Gynecol Obstet; 1979 Dec; 149(6):837-42. PubMed ID: 505258
[TBL] [Abstract][Full Text] [Related]
15. Chemoimmunotherapy in the management of primary stage III ovarian cancer: a Gynecologic Oncology Group study.
Creasman WT; Gall SA; Blessing JA; Schmidt HJ; Abu-Ghazaleh S; Whisnant JK; DiSaia PJ
Cancer Treat Rep; 1979 Feb; 63(2):319-23. PubMed ID: 445505
[TBL] [Abstract][Full Text] [Related]
16. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
Powles R; Toy JL
Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.
Britell JC; Ahmann DL; Bisel HF; Frytak S; Ingle JN; Rubin J; O'Fallon JR
Cancer Clin Trials; 1979; 2(4):345-50. PubMed ID: 394870
[TBL] [Abstract][Full Text] [Related]
18. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
Hortobagyi GN; Yap HY; Blumenschein GR; Gutterman JU; Buzdar AU; Tashima CK; Hersh EM
Cancer Treat Rep; 1978 Nov; 62(11):1685-92. PubMed ID: 728894
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy using BCG during remission induction and as the sole form of maintenance in acute myeloid leukaemia.
Summerfield GP; Gibbs TJ; Bellingham AJ
Br J Cancer; 1979 Nov; 40(5):736-42. PubMed ID: 389265
[TBL] [Abstract][Full Text] [Related]
20. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
